Vancouver, Canada

Marjorie Ann Robbins

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 257(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Marjorie Ann Robbins: A Leading Force in Viral Therapeutics

Introduction

Marjorie Ann Robbins is an accomplished inventor based in Vancouver, Canada. With a remarkable portfolio of 6 patents under her name, she has significantly contributed to the field of viral therapeutics. Her innovative work focuses primarily on developing compositions and methods that target deadly viruses, including the Marburg and Ebola viruses.

Latest Patents

Among her latest patents are groundbreaking inventions aimed at combating viral infections. One notable patent is related to compositions and methods for silencing Marburg virus gene expression. This invention includes compositions comprising siRNA molecules targeting Marburg virus gene expression and lipid particles designed to deliver these molecules effectively. The goal of this invention is to treat infections caused by the Marburg virus.

Another important patent focuses on compositions and methods for silencing Ebola virus gene expression. This invention involves therapeutic nucleic acids like interfering RNA that specifically target the transcription processes of the Ebola virus. Robbins’ work includes innovative solutions to deliver these therapeutic agents in serum-stable lipid particles, designed to prevent or treat infections caused by various strains of the Ebola virus.

Career Highlights

Marjorie Ann Robbins has had a distinguished career, working with notable companies such as Protiva Biotherapeutics, Inc. Her efforts in advancing viral therapeutics are an essential part of her professional journey, demonstrating her commitment to addressing critical health issues through innovative biochemical solutions.

Collaborations

Throughout her career, Robbins has collaborated with several talented individuals, including Ian MacLachlan and Amy C. H. Lee. These partnerships have allowed her to enhance her research and patent work, fostering a collaborative environment that drives innovation in the field of viral treatment.

Conclusion

In summary, Marjorie Ann Robbins stands out as a prominent inventor whose contributions to viral therapeutics are paving the way for new treatment options against severe viruses. Her research and patents not only highlight her innovative spirit but also underscore the importance of targeted therapeutics in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…